Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Nephrolithiasis Treatment Guidelines

Non-Pharmacological Management

  • The American College of Physicians recommends increased fluid intake to achieve at least 2 liters of urine output per day as the first-line treatment for preventing recurrent nephrolithiasis 1, 2
  • Target urine output should be at least 2 liters per day to reduce stone recurrence 2
  • No significant difference has been observed between tap water and mineral water in preventing stone recurrence 3
  • Reducing consumption of soft drinks acidified by phosphoric acid can help reduce stone recurrence 4
  • However, soft drinks acidified by citric acid do not show the same negative effect 3
  • Maintaining normal dietary calcium intake is recommended rather than restricting it 5
  • Limiting dietary oxalate may be beneficial for patients with oxalate stones 5

Pharmacological Management

  • When increased fluid intake fails to prevent stone formation, pharmacologic therapy should be initiated 2
  • Thiazide diuretics are effective in reducing calcium stone recurrence, particularly beneficial for patients with hypercalciuria 2, 3
  • Citrate therapy effectively reduces recurrence of calcium stones by binding to calcium and decreasing urine acidity 2, 3
  • Allopurinol is generally well-tolerated with no increased risk of withdrawals compared to placebo 6
  • Monotherapy is generally as effective as combination therapy for preventing stone recurrence 2
  • Although biochemical testing is commonly used to guide treatment selection, randomized controlled trial evidence supporting this approach is lacking 3

Treatment Algorithm Based on Stone Type

  • For calcium stones, first-line treatment is increased fluid intake to achieve 2L urine output daily, and second-line treatment includes thiazide diuretics for hypercalciuria, citrate supplementation for hypocitraturia, and allopurinol for hyperuricosuria 1, 2, 3